Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Emergent BioSolutions Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 May 2016 Reuters Investment Profile 12 $20.00

Company Snapshot - Emergent Biosolutions Inc

Two Directors at Emergent Biosolutions Inc sold after exercising options/sold 11,835 shares at between 41.220USD and 42.000US...

24 May 2016 Directors Deals Ltd. 1 $12.00

Thomson Reuters Stock Report - Emergent BioSolutions Inc (EBS-N)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 May 2016 Thomson Reuters Stock Report 12 $25.00

Company Snapshot - Erste Group Bank Ag

A director at Erste Group Bank Ag bought 1,000 shares at 23.173EUR and the significance rating of the trade was 52/100. Is t...

13 May 2016 Directors Deals Ltd. 1 $12.00

Trading Report for (EBS). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for EBS. Entry levels, target prices, and risk controls are integral. In addition, free market analy...

13 May 2016 Stock Traders Daily 6 $20.00

Thomson Reuters Stock Report - Emergent BioSolutions Inc (EBS-N)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

13 May 2016 Thomson Reuters Stock Report 12 $25.00

EBS: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

13 May 2016 New Constructs, LLC 10 $25.00

Laidlaw: Emergent BioSolutions (EBS, Buy, $35 PT) October Contract Likely $1B+ Size, Multi-Year

EBS recently reported a surprisingly profitable 1Q16, handily beating us and consensus on both the top & bottom line. The EPS...

11 May 2016 Laidlaw & Company 9 $25.00

Wright Investors Service Comprehensive Report for Emergent BioSolutions, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

11 May 2016 Wright Reports 56 $75.00

ValuEngine Rating and Forecast Report for EBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

08 May 2016 ValuEngine, Inc. 11 $25.00